Posted by Michael Wonder on 17 Dec 2018
Medicines Australia welcomes the Government’s recognition of the importance of medicines
17 December 2018 - Medicines Australia welcomes today’s Mid-Year Economic and Fiscal Outlook, announced by Treasurer the Hon. Josh Frydenberg MP.
The announcements today demonstrate much needed investment into the innovative medicines that Australian patients need, with $1.4 billion in new and amended listings on the Pharmaceutical Benefits Scheme.
Medicines Australia welcomes the new and amended listings announced since the 2018-19 Budget. These new listings are improving access to medicines, including a listing on the Life Saving Drugs Program, for patients with the genetic condition Fabry disease and the provision of $51.8 million over four years to list new vaccines against the A, C, W & Y strains of Meningococcal bacteria and greater access to flu vaccines for indigenous children through the National Immunisation Program.
